FDA.reportPublic FDA data

benzocaine 0.2 MG/MG Oral Gel [Alpha-caine]

RxCUI
1297832
RxNorm name
benzocaine 0.2 MG/MG Oral Gel [Alpha-caine]
Term type
SBD
Status
Active
Updated
2026-06-06 07:16:57

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072012
Active start
072012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Gel346169

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRAlpha-caine 20 % Oral GelNAMES
RxNorm Namebenzocaine 0.2 MG/MG Oral Gel [Alpha-caine]NAMES
RxNorm SynonymAlpha-caine 0.2 MG/MG Oral GelNAMES
RxNorm SynonymAlpha-caine 20 % Oral GelNAMES
TTYSBDATTRIBUTES
SPL_SET_ID719743f9-21fc-4568-b879-acdfa4639464CODES
SPL_SET_IDae628766-25b7-4b4f-abb8-a43faf2f44b9CODES
SPL_SET_IDe6a312e5-17ac-46f0-8723-4e40eeecd69fCODES
SPL_SET_IDff0695a1-1d7d-4b51-97fd-689e56d914feCODES
RxCUI1297832CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
55346-2901-155346-2901Alpha-Caine BenzocaineDental Technologies, Inc.M022
55346-2902-155346-2902Alpha-Caine BenzocaineDental Technologies, Inc.M022
55346-2903-155346-2903Alpha-Caine BenzocaineDental Technologies, Inc.M022
55346-2904-155346-2904Alpha-Caine BenzocaineDental Technologies, Inc.M022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02255346-2901Alpha-Caine BenzocaineOTC MONOGRAPH DRUGDental Technologies, Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
55346290101rxnav_ndcsyes
55346290201rxnav_ndcsyes
55346290301rxnav_ndcsyes
55346290401rxnav_ndcsyes

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ae628766-25b7-4b4f-abb8-a43faf2f44b9ALPHA-CAINE 20 % Oral GelPSN9Alpha-Caine Drug Facts, Mint20251104
ae628766-25b7-4b4f-abb8-a43faf2f44b9Alpha-caine 20 % Oral GelSY9Alpha-Caine Drug Facts, Mint20251104
ae628766-25b7-4b4f-abb8-a43faf2f44b9benzocaine 0.2 MG/MG Oral Gel [Alpha-caine]SBD9Alpha-Caine Drug Facts, Mint20251104
ae628766-25b7-4b4f-abb8-a43faf2f44b9Alpha-caine 0.2 MG/MG Oral GelSY9Alpha-Caine Drug Facts, Mint20251104
e6a312e5-17ac-46f0-8723-4e40eeecd69fAlpha-caine 20 % Oral GelSY9Alpha-Caine Drug Facts - Bubble Gum20251104
e6a312e5-17ac-46f0-8723-4e40eeecd69fbenzocaine 0.2 MG/MG Oral Gel [Alpha-caine]SBD9Alpha-Caine Drug Facts - Bubble Gum20251104
e6a312e5-17ac-46f0-8723-4e40eeecd69fALPHA-CAINE 20 % Oral GelPSN9Alpha-Caine Drug Facts - Bubble Gum20251104
e6a312e5-17ac-46f0-8723-4e40eeecd69fAlpha-caine 0.2 MG/MG Oral GelSY9Alpha-Caine Drug Facts - Bubble Gum20251104
719743f9-21fc-4568-b879-acdfa4639464benzocaine 0.2 MG/MG Oral Gel [Alpha-caine]SBD8Alpha-Caine Drug Facts, Strawberry20251104
719743f9-21fc-4568-b879-acdfa4639464Alpha-caine 0.2 MG/MG Oral GelSY8Alpha-Caine Drug Facts, Strawberry20251104
719743f9-21fc-4568-b879-acdfa4639464Alpha-caine 20 % Oral GelSY8Alpha-Caine Drug Facts, Strawberry20251104
719743f9-21fc-4568-b879-acdfa4639464ALPHA-CAINE 20 % Oral GelPSN8Alpha-Caine Drug Facts, Strawberry20251104
ff0695a1-1d7d-4b51-97fd-689e56d914feAlpha-caine 0.2 MG/MG Oral GelSY8Alpha-Caine Drug Facts, Cherry20251104
ff0695a1-1d7d-4b51-97fd-689e56d914feALPHA-CAINE 20 % Oral GelPSN8Alpha-Caine Drug Facts, Cherry20251104
ff0695a1-1d7d-4b51-97fd-689e56d914feAlpha-caine 20 % Oral GelSY8Alpha-Caine Drug Facts, Cherry20251104
ff0695a1-1d7d-4b51-97fd-689e56d914febenzocaine 0.2 MG/MG Oral Gel [Alpha-caine]SBD8Alpha-Caine Drug Facts, Cherry20251104

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
ae628766-25b7-4b4f-abb8-a43faf2f44b9Alpha-Caine Drug Facts, MintDental Technologies, Inc.20251104
e6a312e5-17ac-46f0-8723-4e40eeecd69fAlpha-Caine Drug Facts - Bubble GumDental Technologies, Inc.20251104
719743f9-21fc-4568-b879-acdfa4639464Alpha-Caine Drug Facts, StrawberryDental Technologies, Inc.20251104
ff0695a1-1d7d-4b51-97fd-689e56d914feAlpha-Caine Drug Facts, CherryDental Technologies, Inc.20251104
ae628766-25b7-4b4f-abb8-a43faf2f44b9Alpha-Caine Drug Facts, MintDental Technologies, Inc.20231120
e6a312e5-17ac-46f0-8723-4e40eeecd69fAlpha-Caine Drug Facts - Bubble GumDental Technologies, Inc.20231120
719743f9-21fc-4568-b879-acdfa4639464Alpha-Caine Drug Facts, StrawberryDental Technologies, Inc.20231120
ff0695a1-1d7d-4b51-97fd-689e56d914feAlpha-Caine Drug Facts, CherryDental Technologies, Inc.20231120

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESRxCUI1297832
CODESSPL_SET_ID719743f9-21fc-4568-b879-acdfa4639464
CODESSPL_SET_IDae628766-25b7-4b4f-abb8-a43faf2f44b9
CODESSPL_SET_IDe6a312e5-17ac-46f0-8723-4e40eeecd69f
CODESSPL_SET_IDff0695a1-1d7d-4b51-97fd-689e56d914fe
NAMESPrescribable SynonymALPHA-CAINE 20 % Oral Gel
NAMESRXNAV_STRAlpha-caine 20 % Oral Gel
NAMESRxNorm Namebenzocaine 0.2 MG/MG Oral Gel [Alpha-caine]
NAMESRxNorm SynonymAlpha-caine 0.2 MG/MG Oral Gel
NAMESRxNorm SynonymAlpha-caine 20 % Oral Gel
SOURCESSourceMetathesaurus FDA Structured Product Labels